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Background: There are limited data regarding impact of chronic alcohol use on
vasospastic angina. We evaluated the impact of alcohol use on coronary artery spasm
(CAS) as assessed with intracoronary acetylcholine (Ach) provocation test.
Methods: A total 3034 consecutive patients [pts, Men 1457 (48.0%), mean age
54.512.4 years who underwent coronary angiography with Ach provocation test were
enrolled. Study population were divided into current alcoholic (912, 30.1%) vs. non
alcoholic (2101, 69.2%) groups. Significant CAS was defined as transient 70% luminal
narrowing with chest pain and/or ST segment changes.
Results: Baseline clinical characteristics were balanced except non alcoholic had more
hypertension (49.3% vs. 40.4%, P0.001), diabetes (13.6% vs. 10.2%, P0.009),
peripheral vascular disease (6.3% vs.3.0%, P0.001), history of CVA (3.5% vs.2.1%,
P0.041), congestive heart failure (2.0% vs.0.5%, P0.004) whereas alcoholic group were
mostly men (76.5% vs.35.8%,P0.001) and had more current smokers (42.8% vs.
13.8%,P0.001). Although the alcoholic group showed higher incidence of myocardial
bridge, Ach induced CAS, and severe narrowing on QCA on univariate analysis, however,
after adjusting the baseline differences, all clinical and angiographic parameters of Ach
provocation test were not different between the two groups (Table).
Conclusions: In our study, current alcohol use was not associated with clinical and
angiographic characteristics of CAS as assessed with Ach provocation test.
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Background: Ergnovine(Erg) and Acetylcholine (Ach)isanuseful agent forassessing
significant coronary artery spasm (CAS). However, clinical data regardingcombined or
simultaneous intracoronary provocation test using these two agents are largely unknown.
Methods: A total 113consecutive patients (pts)underwent Ergand/ or Ach provocation
test were enrolled. Erg test was performed by incremental doses of 5, 10, 25ug. If Erg test
is (-), subsequentAch test was done by 20, 50, 100ug. Significant CAS was defined as
focal or diffuse severe transient luminal narrowing (70%) with/without chest pain or
ST-T change on ECG. We investigated the overall results of simultaneous Erg and Ach
provocation test.
Results: Baselineclinical characteristics showed that mean age was 53.18 9.8 years old
(male 69.3%), hypertension 48.7%, diabetes 6.1%, dyslipidemia 12.2% and smoking
34.6%. A total 49pts (49/113, 43.4%) showed () provocation test by Erg. Sixteen % of
the pts responded to E2 dose (10ug) and 83.6% to E3 (25ug). Multivesselspasm was in
32.7%, and diffuse spasm 16.3%. A total 64 pts who were (-) to Erg test underwent Ach
provocation test. A total 60 pts (60/64, 93.8%) showed () provocation test by Ach.
Eleven % of the ptsresponded to A1 dose (20ug) and 35.0% to A2 (50ug). Multivessel-
spasm was in 47.5%, and diffuse spasm 8.3%. Only 4 pts (4/113, 3.5%) were (-) response
to both Erg and Ach test.
Conclusion: Both Erg and Ach were safe but Ach was more sensitive and Erg seems to
be more specific to show significant CAS.
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Serum NGAL as a biomarker for subclinical contrast induced nephropathy (CIN) in
diabetic patients with renal impairment at 24 hours post coronary catheterization.
Background: Serum NGAL has been shown to be a novel biomarker for acute kidney
injury. Studies done previously showed that serum NGAL level peak at 4 hours after the
administration of a contrast agent as opposed to serum creatinine. Recently the term
‘subclinical acute kidney injury’ plays an important role, as it increases morbidity and
mortality. Using serum NGAL as a marker, we aim to uncover the incidence of subclinical
CIN on a population of diabetic patients with renal impairment undergoing elective
coronary angiogram in Cardiology Unit University Malaya Medical Centre.
Objectives: To evaluate incidence of subclinical CIN in diabetic patients with renal
impairment undergo elective coronary angiogram using new and conventional biomarker.
Methodology: This is a prospective study of 70 consecutive patients who fulfilled the
following inclusion criteria:
1. Elective admission for coronary angiogram.
2. Stage 3 & 4 diabetic CKD with MDRD equation.
3. Not on nephrotoxic drug 48 hours prior to the study.
The blood samples were taken at 0H; 4H and 24H post coronary angiogram and sent
for serum creatinine (sCr) and NGAL measurement using Alere Triage® NGAL Test.
Results: Out of the 70 samples taken, 25.7% received intravenous saline infusion and
oral N-acetyl-cysteine (NAC) for CIN prophylaxis. Mean age of the patients was 66.8
4.7 years with mean estimated GFR of 45.3 13.6 mls/min/1.73m2. Twelve point eight
percents (12.8%) patients were diagnosed as CIN based on increment 25% serum
creatinine from the baseline. There was a significant raised of serum NGAL at 4 hours
after contrast administration in 77.1% of the patients without raised serum creatinine
suggesting subclinical acute kidney injury. The magnitude of NGAL increment was
significantly lower in the goups receiving CIN prophylaxis (4.8 ng/ml vs 42.3 ng/ml, p
0.001), suggestive protective effect of prophylaxis.
Conclusion: Serum NGAL level is a useful acute clinical marker for CIN post coronary
angiogram in high-risk patients as the level raised as early as 4H compared to serum
creatinine. Our high-risk cohort has 77.1% incidence of subclinical AKI, higher compared
to previous study. Patients who received CIN prophylaxis had lesser magnitude of tubular
injury compared to those who were not given.
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Introduction: Frequency and gravity of heart failure (HF) led to the need for precise risk
stratification. The association with renal failure worsens the prognosis. Cystatin C, an
accurate glomerular filtration rate (GFR) marker, may have a prognostic value in heart
failure patients.
Aim: To evaluate the mortality predictive value of Cystatin C in patients with HF.
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